Vnitr Lek 2014, 60(9):684-690

Factors causing damage and destruction of beta-cells of the islets of Langerhans in the pancreas

Michal Anděl*, Vlasta Němcová, Nela Pavlíková, Jana Urbanová, Marie Čecháková, Andrea Havlová, Radka Straková, Livia Večeřová, Václav Mandys, Jan Kovář, Petr Heneberg, Jan Trnka, Jan Polák
Centrum výzkumu diabetu, metabolizmu a výživy 3. LF UK a FN Královské Vinohrady Praha, přednosta prof. MUDr. Michal Anděl, CSc.

Insulin secretion in patients with manifested diabetes mellitus tends to disappear months to decades after the diagnosis, which is a clear sign of a gradual loss of pancreatic islet beta-cells. In our sample of 30 type 2 diabetic patients, whose disease manifested between 30 and 45 years of age, about a half have retained or even increased insulin secretion 30 years later, while the other half exhibit a much diminished or lost insulin secretion. Factors that can damage or destroy beta-cells can be divided into the following groups:

Metabolic factors: hyperglycemia and glucotoxicity, lipotoxicity, hypoxia, reactive oxygen species;

Pharmacological factors: antimicrobial medication pentamidine, SSRI antidepressants;

Factors related to impaired insulin secretion: MODY type diabetes;

Environmental toxic factors: rat poison Vacor, streptozotocin, polychlorinated and polybrominated hydrocarbons;

Disorders of the exocrine pancreas: tumor infiltration, fibrous infiltration, chronic pancreatitis, cystic fibrosis;

Infections, inflammation, autoimmunity, viral factors: Coxsackie viruses, H1N1 influenza, enteroviruses. We are currently working on finding other factors leading to beta-cell damage, studying their effect on apoptosis and necrosis and looking for possible protective factors to prevent this damage. We our increasing knowledge about the mechanisms of beta-cell damage and destruction we come ever closer to suggest measures for their prevention. In this review we offer a brief and simplified summary of some of the findings related to this area.

Keywords: pancreatic islet beta-cells of Langerhans; factors damaging or destroying beta-cells; insulin secretion

Received: July 21, 2014; Accepted: July 24, 2014; Published: September 1, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Anděl M, Němcová V, Pavlíková N, Urbanová J, Čecháková M, Havlová A, et al.. Factors causing damage and destruction of beta-cells of the islets of Langerhans in the pancreas. Vnitr Lek. 2014;60(9):684-690.
Download citation

References

  1. Anděl M, Kraml P, Šilhová E. Hypoglykémie a sekundární diabetes po pentamidinu. DMEV 2011; 14(2): 68-70.
  2. Anděl M, Polák J, Kraml P et al. Chronický mírný zánět spojuje obezitu, metabolický syndrom, aterosklerózu a diabetes. Vnitř Lék 2009; 55(7): 659-665. Go to PubMed...
  3. Biden TJ, Boslem E, Chu KY et al. Lipotoxic endoplasmic reticulum stress, B cell failure, and type 2 diabetes mellitus. Trends Endocrinol Metab 2014; 25(8): 389-398. Go to original source... Go to PubMed...
  4. Bloch K, Vennäng J, Lazard D et al. Different susceptibility of rat pancreatic alpha and beta cells to hypoxia. Histochem Cell Biol 2012; 137(6): 801-810. Go to original source... Go to PubMed...
  5. Broniowska KA, Oleson BJ, Corbet JA. B-cell responses to nitric oxide. Vitam Horm 2014; 95: 299-322. Go to original source... Go to PubMed...
  6. Codru N, Schymura MJ, Negoita S et al. Diabetes and relation to serum levels of polychlorinated biphenyls and chlorinated pesticides an adult native Americans. Environ Health Perspect 2007; 115(10): 1442-1447. Go to original source... Go to PubMed...
  7. Cox S, Niskar AS, Narayan KMV et al. Prevalence of self-reported diabetes and exposure to organochlorine pesticides among Mexican Americans: Hispanic Health and Nutrition Examination Survey, 1982-1984. Environ Health Perspect 2007; 115(12): 1747-1752. Go to original source... Go to PubMed...
  8. Crinnion WJ. The Role of Persistent Organic Pollutants in the Worldwide Epidemic of Type 2 Diabetes Mellitus and the Possible Connection to Farmed Atlantic Salmon (Salmo salar). Altern Med Rev 2011; 16(4): 301-313.
  9. Čecháková M, Kratochvíl A, Anděl M. MIkrovaskulární komplikace u pacientů s diabetes mellitus 2. typu manifestovaném mezi 30. a 45. rokem s trváním diabetu nad 30 let na základě hodnocení inzulinosekrece a kompenzace (poster 38). Abstrakta 50. Luhačovických diabetologických dnů. DMEV 2014; 17(Suppl): 54.
  10. Dhayal S, Welters HJ, Morgan NG. Structural requirements for the cytoprotective actions of mono-unsaturated fatty acids in the pancreatic beta-cell line, BRIN-BD11. Br J Pharmacol 2008; 153(8): 1718-1727. Go to original source... Go to PubMed...
  11. De Long NE, Hyslop JR, Raha S et al. Fluoxetine-induced pancreatic beta-cell dysfunction: New insight into benefits of folic acid in the treatment of depression. J Affect Disord 2014; 166: 6-13. Go to original source... Go to PubMed...
  12. Everett CJ, Frithsen I, Player M. Relationship of polychlorinated biphenyls with type 2 diabetes and hypertension. J Environ Monit 2011; 13(2): 241-251. Go to original source... Go to PubMed...
  13. Everett CJ, Matheson EM. Biomarkers of pesticide exposure and diabetes in the 1999-2004 National Health and Nutrition Examination Survey. Environ Int 2010; 36(4):398-401. Go to original source... Go to PubMed...
  14. Eitel K, Staiger H, Brendel MD et al. Different role of saturated and unsaturated fatty acids in beta-cell apoptosis. Biochem Biophys Res Commun 2002; 299(5): 853-856. Go to original source... Go to PubMed...
  15. Fonsenca V, John-Kalarickal J. Type 2 Diabetes Mellitus: Epidemiology, Genetics, Pathogenesis and clinical Manifestations. In: Poretsky L (ed). Principles of Diabetes Mellitus. 2nd ed. Springer: New York, Dordrecht, Heidelberg, London 2010: 203-220. ISBN 978-0-387-09840-1. Go to original source...
  16. Fürstova V, Kopska T, James RF et al. Comparison of the effect of individual saturated and unsaturated fatty acids on cell growth and death induction in the human pancreatic beta-cell line NES2Y. Life Sci 2008; 82(13-14): 684-691. Go to original source... Go to PubMed...
  17. Fernandez C, Fransson U, Hallgard E et al. Metabolic and proteomic analysis of a clonal insulin-producing beta-cell line (INS-1 832/13). J Proteome Res 2008; 7(1): 400-411. Go to original source... Go to PubMed...
  18. Galadari S, Rahman A, Pallichankandy S et al. Role of ceramide in diabetes mellitus: evidence and mechanisms. Lipids Health Dis 2013; 12: 12-98. Dostupné z DOI: <http://doi:10.1186/1476-511X-12-98>. Go to original source... Go to PubMed...
  19. Garger YB, Joshi PM, Pareek AS et al. Secondary Causes of Diabetes Mellitus. In: Poretsky L (ed.): Principles of Diabetes Mellitus. (2nd ed). Springer: New York, Dordrecht, Heidelberg, London 2010: 245-258. ISBN 978-0-387-09840-1. Go to original source...
  20. Gray SL, Shaw AC, Gagne AX et al. Chronic exposure to PCBs (Aroclor 1254) exacerbates obesity-induced insulin resistance and hyperinsulinemia in mice. J Toxicol Environ Health A 2013; 76(12): 701-715. Go to original source... Go to PubMed...
  21. Gurzov EN, Eizirik DL. Bcl-2 proteins in diabetes: mitochondrial pathways of B-cell death and dysfunction. Trends Cell Biol 2011; 21(7): 424-431. Go to original source... Go to PubMed...
  22. Hovsepyan M, Sargsyan E, Bergsten P. Palmitate-induced changes in protein expression of insulin secreting INS-1E cells. J Proteomics 2010; 73(6): 1148-1155. Go to original source... Go to PubMed...
  23. Howell GE, Meek E, Kilic J et al. Exposure to p,p'-dichlorodiphenyldichloroethylene (DDE) induces fasting hyperglycemia without insulin resistance in male C57BL/6H mice. Toxicology 2014; 320: 6-14. Go to original source... Go to PubMed...
  24. Hui H, Dotta F, Di Mario U et al. Role of caspases in the regulation of apoptotic pancreatic islet beta-cells death. J Cell Physiol 2004; 200(2): 177-200. Go to original source... Go to PubMed...
  25. Christopher RJ, Takeuchi K, Lee B. Rodent models of diabetes. In: Poretsky L (ed). Principles of Diabetes Mellitus. (2nd ed). Springer: New York, Dordrecht, Heidelberg, London 2010: 165-178. ISBN 978-0-387-09840-1. Go to original source...
  26. Ibrahim MM, Fjaere E, Lock EJ et al. Metabolic impacts of high dietary exposure to persistent organic pollutants in mice. Toxicol Lett 2012; 215(1): 8-15. Go to original source... Go to PubMed...
  27. Ibrahim MM, Fjaere E, Lock EJ et al. Chronic Consumption of Farmed Salmon Containing Persistent Organic Pollutants Causes Insulin Resistance and Obesity in Mice. PloS One 2011; 6(9): e25170. Dostupné z DOI: <http://doi:10.1371/journal.pone.0025170>. Go to original source... Go to PubMed...
  28. Jaberi-Douraki M, Schnell S, Pietropaolo M et al. Unraveling the contribution of pancreatic betas-cell suicide in autoimmune type-1 diabetes. J Theor Biol 2014; 5193: S0022-00270. Dostupné z DOI: <http://10.1016/j.jtbi.2014.05.003>. Go to original source... Go to PubMed...
  29. Johnson D, Kubic P, Levitt C. Accidental ingestion of Vacor rodenticide: the symptoms and sequelae in a 25-month-old child. Am J Dis Child 1980; 134(2): 161-164. Go to original source... Go to PubMed...
  30. Kamata K, Mizukami H, Inaba W et al. Islet amyloid with macrophage migration correlates with augmented b-cell deficit in type 2 diabetic patients. Amyloid 2014; 35: 1-11. Epub ahead of print. Go to original source... Go to PubMed...
  31. Karam JH, Lewitt PA, Young CW et al. Insulinopenic diabetes after rodenticide (Vacor) ingestion: a unique model of acquired diabetes in man. Diabetes 1980; 29(12): 971-978. Go to original source... Go to PubMed...
  32. Leahy JL. Beta-cell dysfunction In: Kahn CR, King GL, Moses A et al (eds). Joslin's Diabetes Mellitus. Selected chapters from Fourteenth Edition. Lippincott Williams and Williams: Boston 2004: 223-235. ISBN 9780781727969.
  33. Maedler K, Spinas GA, Dyntar D et al. Distinct effects of saturated and monounsaturated fatty acids on beta-cell turnover and function. Diabetes 2001; 50(1): 69-76. Go to original source... Go to PubMed...
  34. Mandys V, Kheck M, Anděl M. Granulomatous pancreatitis in a patient with acute manifested insulin-dependent diabetes mellitus. Case Rep Pathol 2014; 615426. Dostupné z DOI: <http://doi:10.1155/2014/615426>. Go to original source... Go to PubMed...
  35. Mesarwi O, Polak J, Jun J et al. Sleep disorders and the development of insulin resistance and obesity. Endocrinol Metab Clin North Am 2013; 42(3): 617-634. Go to original source... Go to PubMed...
  36. Morgan NG, Dhayal S. Unsaturated fatty acids as cytoprotective agents in the pancreatic beta-cell. Prostaglandins Leukot Essent Fatty Acids 2010; 82(4-6): 231-236. Go to original source... Go to PubMed...
  37. Němcová-Fürstová V, James RF, Kovář J. Inhibitory effect of unsaturated fatty acids on saturated fatty acid-induced apoptosis in human pancreatic B-cells: activation of caspases and ER stress induction. Cell Physiol Biochem 2011; 27(5): 525-538. Go to original source... Go to PubMed...
  38. Nemcova-Furstova V, Balusikova K, Sramek J et al. Caspase-2 and JNK activated by saturated fatty acids are not involved in apoptosis induction but modulate ER stress in human pancreatic B-cells. Cell Physiol Biochem 2013; 31(2-3): 277-289. Go to original source... Go to PubMed...
  39. Němcová-Fürstová V, James RF, Kovář J. Comparison of the effect of individual saturated and unsaturated fatty acids on cell growth and death induction in the human pancreatic beta-cell line NES2Y. Life Sci 2008: 26; 82(13-14):684-691. Go to original source... Go to PubMed...
  40. Ozcan U, Cao Q, Yilmaz E et al. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 2004; 306(5695): 457-461. Go to original source... Go to PubMed...
  41. Pallayova M, Lazurova I, Donic V. Hypoxic damage to pancreatic beta cells-the hidden link between sleep apnea and diabetes. Med Hypotheses 2011; 77(5): 930-934. Go to original source... Go to PubMed...
  42. Pi J, Collins S. Reactive oxygen species and uncoupling protein 2 in pancreatic B-cell function. Diabetes Obes Metab 2010; 12(Suppl 2): S141-S148. Go to original source... Go to PubMed...
  43. Polak J, Shimoda LA, Drager LF et al. Intermittent hypoxia impairs glucose homeostasis in C57BL6/J mice: partial improvement with cessation of the exposure. Sleep 2013; 36(10): 1483-1490. Go to original source... Go to PubMed...
  44. Pont A, Rubino JM, Bishop D et al. Diabetes mellitus and neuropathy following Vacor ingestion in man. Arch Intern Med 1979; 139(2): 185-187. Go to original source...
  45. Ruzzin J, Petersen R, Meugnier E et al. Persistent Organic Pollutant Exposure Leads to Insulin Resistance Syndrome. Environ Health Perspect 2009; 118(4): 465-471. Go to original source...
  46. Sato Y, Fujimoto S, Mukai E et al. Palmitate induces reactive oxygen species production and B-cell dysfunction by activating nicotinamide adenine dinucleotide phosphate oxidase through Src signaling. J Diabetes Investig 2014; 5(1):19-26. Go to original source... Go to PubMed...
  47. Smiley T. The role of declining beta cell function in the progression of type 2 diabetes: implications for outcomes and pharmacological management. Can J Diabetes 2003; 27(3): 277-286.
  48. Son HK, Kim SA, Kang JH et al. Strong associations between low-dose organochlorine pesticides and type 2 diabetes in Korea. Environ Int 2010; 36(5): 410-414. Go to original source... Go to PubMed...
  49. Sone H, Kagawa Y. Pancreatic beta cell senescence contributes to the pathogenesis of type 2 diabetes in high-fat diet-induced diabetic mice. Diabetologia 2005; 48(1): 58-67. Go to original source... Go to PubMed...
  50. Swaminathan S, Fonseca V, Alam M et al. The role of iron in diabetes and its complications. Diabetes Care 2007; 30(7): 1926-1933. Go to original source... Go to PubMed...
  51. Škrha J. Patogeneze diabetes mellitus 1. a 2. typu v roce 2011 - jednotící model poruchy glykoregulace. Vnitř Lék 2011; 57(11): 949-953. Go to PubMed...
  52. Tan L, Ye X, Zhou Y et al. Macrophage migration inhibitory factor is overexpressed in pancreatic cancer tissues and impairs insulin secretion of b-cell. J Transl Med 2014; 12: 92. Dostupné z DOI: <http://doi:10.1186/1479-5876-12-92>. Go to original source... Go to PubMed...
  53. Tittlbach M. Ostrůvky pankreatu, fylogenetický a ontogenetický vývoj, primární struktury hormonů. In: Anděl M, Saudek F, Klimeš I (eds). Horizonty diabetologie. Díl 1. Tigis: Praha 2001. ISBN 80-900130-1-7.
  54. Uchizono Y, Baldwin AC, Sakuma H et al. Role of HNF-1α in regulating the expression of genes involved in cellular growth and proliferation in pancreatic beta-cells. Diabetes Res Clin Pract 2009; 84(1):19-26. Go to original source... Go to PubMed...
  55. Urbanová J, Rypáčková B, Procházková Z et al. Positivity for islet cell autoantibodies in patients with monogenic diabetes is associated with later diabetes onset and higher HbA1c level. Diabet Med 2014; 31(4): 466-471. Go to original source... Go to PubMed...
  56. Urbanová J, Rypáčková B, Kučera P et al. Should the negativity for islet cell autoantibodies be used in a prescreening for genetic testing in maturity-onset diabetes of the young? The case of autoimmunity-associated destruction of pancreatic B-cells in a family of HNF1A-MODY subjects. Int Arch Allergy Immunol 2013; 161(3): 279-284. Go to original source... Go to PubMed...
  57. Welters HJ, Tadayyon M, Scarpello JH et al. Mono-unsaturated fatty acids protect against beta-cell apoptosis induced by saturated fatty acids, serum withdrawal or cytokine exposure. FEBS Lett 2004; 560(1-3): 103-108. Go to original source... Go to PubMed...
  58. Wobser H, Düssmann H, Kögel D et al. Dominant-negative suppression of HNF-1 alpha results in mitochondrial dysfunction, INS-1 cell apoptosis, and increased sensitivity to ceramide-, but not to high glucose-induced cell death. J Biol Chem 2001; 277(8): 6413-6421. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.